Industry Relations and Technology Transfer

Express Licenses

Fred Hutchinson Cancer Research Center has developed a variety of monoclonal antibodies and other research tools that may be obtained using an Express License. These license agreements have standard terms and conditions that are intended to offer our partners quick and convenient access.

If the express license does not meet your specific needs, contact our office to discuss other possible arrangements.

View our catalogue of monoclonal antibodies »

Download our Express License agreement »

Can’t find what you are looking for? Search our Available Technologies database for more options or contact irtto@fhcrc.org.   

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.